The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…
BMI View: Sri Lanka's pharmaceutical and healthcare markets will continue to expand over the next 10
years driven by economic development. Despite an increased level of fiscal tightening in the coming
quarters, healthcare system strengthening and facilities upgrade will remain a policy priority. We expect
growing demand for healthcare and medical treatment of chronic diseases to create commercial
opportunities for drugmakers and medical operators, although the government's pro-generic drugs stance
and low spending per capita on medicine will continue to tarnish the market potential appeal to innovative
Headline Expenditure Projections
? Pharmaceuticals: LKR82.88bn (USD610mn) in 2015 to LKR90.57bn (USD610mn) in 2016; +9.3 in
local currency terms and +0.4 in US dollar terms. Forecast broadly in line with last quarter.
? Healthcare: LKR273.32bn (USD2.01bn) in 2015 to LKR293.79bn (USD1.99bn) in 2016; +7.5 in local
currency terms and -1.2 in US dollar terms. Forecast revised downwards from last quarter.